Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23276
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPearce, Samuel-
dc.contributor.authorMaingard, Julian T-
dc.contributor.authorLi, Kenny-
dc.contributor.authorKok, Hong Kuan-
dc.contributor.authorBarras, Christen D-
dc.contributor.authorRussell, Jeremy H-
dc.contributor.authorHirsch, Joshua A-
dc.contributor.authorChandra, Ronil V-
dc.contributor.authorJhamb, Ash-
dc.contributor.authorThijs, Vincent N-
dc.contributor.authorBrooks, Duncan Mark-
dc.contributor.authorAsadi, Hamed-
dc.date2020-
dc.date.accessioned2020-05-25T05:23:34Z-
dc.date.available2020-05-25T05:23:34Z-
dc.date.issued2020-05-18-
dc.identifier.citationClinical neuroradiology 2020; online first: 18 May-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/23276-
dc.description.abstractThe development of endovascular treatment for intracranial aneurysms has established new techniques such as balloon and stent-assistance, flow diversion and endosaccular occlusion devices. Antiplatelet treatment is an important aspect to reduce risk of thrombus formation on microcatheters and implanted devices when utilizing these methods. It is particularly relevant for flow diverting stents to prevent early and late stent thrombosis. Consideration of platelet physiology and appropriate selection of antiplatelet medication is important as platelet dysfunction drives many of the pathological processes and complications of neurointerventional procedures. Part one of this review focuses on basic platelet physiology, pharmacology of common antiplatelet medications and future directions and therapies. Part two focuses on clinical applications and evidence-based therapeutic regimens.-
dc.language.isoeng-
dc.subjectAneurysm-
dc.subjectCoiling-
dc.subjectFlow diverting-
dc.subjectIntracranial-
dc.subjectStent-
dc.titleAntiplatelet Drugs for Neurointerventions: Part 1 Clinical Pharmacology.-
dc.typeJournal Article-
dc.identifier.journaltitleClinical neuroradiology-
dc.identifier.affiliationDepartment of Neurosurgery, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationMassachusetts General Hospital, Harvard Medical School, Boston, MA, USAen
dc.identifier.affiliationDepartment of Neurology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationInterventional Neuroradiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationInterventional Neuroradiology, St Vincent's Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationInterventional Neuroradiology Unit, Monash Imaging, Monash Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSchool of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria, Australiaen
dc.identifier.affiliationInterventional Radiology Service, Department of Radiology, Northern Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSouth Australian Institute of Health and Medical Research, Adelaide, South Australia, Australiaen
dc.identifier.affiliationSchool of Medicine, The University of Adelaide, Adelaide, South Australia, Australiaen
dc.identifier.affiliationDepartment of Imaging, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationStroke Division, Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSchool of Medicine, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1007/s00062-020-00910-5-
dc.identifier.orcid0000-0003-3692-120Xen
dc.identifier.orcid0000-0002-6614-8417en
dc.identifier.orcid0000-0001-5034-570Xen
dc.identifier.orcid0000-0003-2475-9727en
dc.identifier.pubmedid32424668-
dc.type.austinJournal Article-
dc.type.austinReview-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Jun 24, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.